Fact CheckerSign in

NCT06718842Recruiting

Walking Program in Fatty Liver Children With Phenylketonuria

Walking Program in Fatty Liver Children With Phenylketonuria: Response of Liver Enzymes

Source: ClinicalTrials.gov · Last updated 5 Dec 2024 · Not updated for over 12 months - ask the site whether it is still open

Brief summary (registry, in English)

phenylketonuria (commonly known as PKU) is an inherited disorder that increases the levels of a substance called phenylalanine in the blood. PKU is usually associated with many metabolic complication including non-alcoholic fatty liver

Status (registry)
Recruiting
Study type
Interventional
Enrollment
40 (estimated)
First submitted
2 Dec 2024
Start date
15 Sept 2024
Primary completion date
30 Jan 2025
Lead sponsor
Cairo University
NCT number
NCT06718842

What you commit to

  • Study type: Interventional
  • Planned participants: 40
  • From 15 Sept 2024 to the primary completion date, 30 Jan 2025
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Other illness

  • cardiac children
  • neurogenic disorders

Other

  • diabetic children
  • respiratory and renal problems

Who the study is looking for

  • PKU children
  • obese children
  • fatty liver children (non-alcoholic fatty liver)

Age in the registry: 9 years to 12 years · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
Cairo University
Coordinator of this site? Confirm its status
DokkiEgyptRecruiting

Related publications

This page is information, not medical advice. Discuss any trial with your doctor.